Kimberly Chapman
Family Medicine · Bentonville, ARNPI 1821056441
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 117 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 15.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,103 and has fallen 98.2% since, to $20 in 2024.
Across 117 payments — averaging $13.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$246
- Merck$152
- Amgen$135
- Takeda Pharmaceuticals U.S.A., Inc.$134
- GSK$133
- Pfizer$119
- plus $684 from 16 others
What the payments were for
- Food & beverage$1,601100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 3 | $246 |
| Merck | 18 | $152 |
| Amgen(2 entities) | 7 | $135 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $134 |
| GSK | 21 | $133 |
| Pfizer | 13 | $119 |
| Astellas Pharma US Inc | 7 | $105 |
| Gilead | 1 | $100 |
| Novo Nordisk | 4 | $85 |
| Boehringer Ingelheim | 5 | $71 |
| Genentech USA, Inc. | 4 | $66 |
| AstraZeneca | 3 | $39 |
| Amarin Pharma, Inc. | 2 | $36 |
| Supernus Pharmaceuticals, Inc. | 2 | $35 |
| Sunovion Pharmaceuticals Inc. | 3 | $28 |
| Johnson & Johnson | 2 | $27 |
| Sanofi-aventis U.S. LLC | 2 | $22 |
| Abbott | 2 | $20 |
| Nalpropion Pharmaceuticals LLC | 1 | $15 |
| Eisai Inc. | 1 | $12 |
| Kowa Pharmaceuticals America, Inc. | 1 | $11 |
| Lilly USA, LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,601 in reported general payments places this provider in the 65th percentile of 1,347 family medicine providers in Arkansas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fentanyl | 18 | $1,870 |
| Olmesartan-HydrochlorothiazideOlmesartan/Hydrochlorothiazide | 13 | $687 |
| Gabapentin | 30 | $641 |
| Morphine Sulfate | 15 | $595 |
| Celecoxib | 14 | $543 |
| Hydromorphone Hcl | 12 | $494 |
| Butalbital-Acetaminophen-CaffeButalb/Acetaminophen/Caffeine | 11 | $484 |
| Olmesartan Medoxomil | 21 | $473 |
| Metformin Hcl | 14 | $469 |
| Omeprazole | 40 | $380 |
| Rosuvastatin Calcium | 16 | $369 |
| Pantoprazole Sodium | 22 | $302 |
| Clonazepam | 22 | $300 |
| ClopidogrelClopidogrel Bisulfate | 15 | $276 |
| Primidone | 16 | $259 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Bentonville
- Scott MusickBentonville$102K
- Craig LevoyBentonville$30K
- Rossitza HristoskovaBentonville$14K
- Graeme ArcherBentonville$13K
- Glenn GibbonsFort Smith$179K
- Hetal PatelParagould$147K
- David GersonSherwood$119K
- Broderick EatonWynne$49K
- Allen BeachyFort Smith$21K
- Hunter CarringtonHot Springs$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.